337 results on '"Darbari, Deepika S."'
Search Results
2. Diagnostic Potential of Platelet-Neutrophil Ratio (PNR) for Stroke Risk in SCD Children
3. Platelet to Neutrophil Ratio as a Novel Marker for Monitoring SCD Patients on Hydroxyurea
4. Alteration of grey matter volume is associated with pain and quality of life in children with sickle cell disease
5. Review/overview of pain in sickle cell disease
6. Life after sickle cell disease, is it really uhuru?
7. End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain
8. Current Non-HSCT Treatments for SCD
9. Feasibility and preliminary efficacy of the Balance Program to reduce pain‐related disability in pediatric sickle cell disease
10. Evaluating Microalbuminuria in Children with Sickle Cell Disease: Review of the Literature
11. Targeted Hydroxyurea Education after an Emergency Department Visit Increases Hydroxyurea Use in Children with Sickle Cell Anemia
12. Comprehensive Infant Clinic for Sickle Cell Disease: Outcomes and Parental Perspective
13. Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia
14. Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke
15. Optimising the screening for haemoglobinopathies in pregnancy planning.
16. The evolution of the COVID ‐19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron
17. Neurocognitive and emotional factors predict pain‐related healthcare utilization in children with sickle cell disease
18. Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital
19. Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease
20. A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children
21. Telemedicine in sickle cell disease: Patient, parent, and provider perspectives
22. Interim Analysis of a Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Sickle Cell Disease Patients with Priapism (SPARTAN)
23. Real World Applications of Clinical Whole Blood Adhesion (VCAM and P-selectin) Biomarkers in a Pediatric SCD Population
24. Expansion of Content in the Phenx Toolkit for Sickle Cell Disease Pain
25. Preliminary Feasibility and Efficacy of the Balance Program to Reduce Pain-Related Disability in Pediatric Sickle Cell Disease
26. In memoriam: Samir K. Ballas (1938–2022)
27. Current Non-HSCT Treatments for SCD
28. Telemedicine in sickle cell disease: Patient, parent, and provider perspectives.
29. Complementary and Integrative Medicine Use in Pediatric Patients with Sickle Cell Disease
30. Increased Clearance of Morphine in Sickle Cell Disease: Implications for Pain Management
31. Acupuncture as an Adjunctive Treatment for Pain in Hospitalized Children With Sickle Cell Disease
32. Spirometric Changes After Initiation of Hydroxyurea in Children With Sickle Cell Anemia
33. Integrative holistic approaches for children, adolescents, and young adults with sickle cell disease: A single center experience
34. Pediatric Sickle Cell Disease and the COVID-19 Pandemic: A Year in Review at Children's National Hospital
35. Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease
36. Alteration of grey matter volume is associated with pain and quality of life in children with sickle cell disease
37. The Role of Red Blood Cell Vascular Adhesion Biomarkers in Understanding Sickle Cell Disease Associated Chronic Pain
38. The Impact of Socio-Economic Determinants of Health on PedsQL and Pain Outcomes Among Individuals with Sickle Cell Disease
39. Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism
40. Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia
41. Thinking beyond sickling to better understand pain in sickle cell disease
42. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia
43. A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia
44. Acupuncture for pain management in children with sickle cell disease
45. Neuropathy, neuropathic pain, and sickle cell disease
46. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease
47. Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease*
48. Safety and efficacy of catheter directed thrombolysis in children with deep venous thrombosis
49. Markers of Severe Vaso-Occlusive Painful Episode Frequency in Children and Adolescents with Sickle Cell Anemia
50. Cognitive and Emotional Factors and Pain-Related Outcomes in Youth with Sickle Cell Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.